Lanton Law
Home
About
Practice Areas
Legal Services
Lobbying
Blog
Contact
Lanton Law
Home
About
Practice Areas
Legal Services
Lobbying
Blog
Contact

Lanton Law Blog

Learn about the latest trends and activities through our blog posts.

Lanton Law Interviews the Massachusetts Pharmacists Association on DIR & Provider Status

We are excited to have Lindsay De Santis; Executive Vice President of the Massachusetts Pharmacists Association (MPhA) do a blogcast with us. Our conversation covers pharmacy DIR (direct and indirect remuneration) fees, pharmacy provider status and COVID-19.

Click here to access the Lanton Law blogcast.

life sciences, pharmaceuticals, pharmacy, reimbursement, Medicare Part B, Medicare Part DRon LantonMay 19, 2020DIR fee, DIR, direct and indirect remuneration fees, pharmacy provider status, provider status, COVID-19, Massachusetts, Massachusetts Pharmacists Association
0 Likes
Previous

Apple and Google Announce Digital Contact Tracing Partnership Amid Privacy Concerns

data privacy, healthcare, HealthIT, life sciences, pharmaceuticals, tech, technology, privacyRon LantonMay 21, 2020Apple, Google, Facebook, CDC, contact tracing, digital contact tracing, Project Nightingale
Next

Will Immunity Passports Lead to Future Genetic Discrimination?

biologics, Biosimilars, data privacy, healthcare, insurance, life sciences, pharmaceuticals, pharmacy, physician, technology, techRon LantonMay 14, 2020GINA, Genetic Information Nondiscrimination Act, COVID-19, tracing, National Institutes of Health, NIH, immunity passport